Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FXJWY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,628
Award facts
- Contract value 100% obligated
- $17,628.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,628.28 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 ml syringes on July 23, 2025, with completion scheduled for July 24, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Stelara is a biologic immunosuppressant used to treat autoimmune conditions, and this delivery order represents a routine pharmaceutical procurement to support federal medical supply needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies that serve military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations worldwide. The company's demonstrated capability to fulfill diverse pharmaceutical requirements through competitive procurement makes it a key partner in supporting the DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FXJWY?
SPE2DB25FXJWY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FXJWY worth?
The government has obligated $17,628 on SPE2DB25FXJWY.
Is contract SPE2DB25FXJWY an order under another contract?
Yes. SPE2DB25FXJWY is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB25FXJWY competed?
The extent of competition for SPE2DB25FXJWY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award